SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-046870
Filing Date
2012-02-08
Accepted
2012-02-08 17:17:59
Documents
2
Period of Report
2012-02-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d297413d8k.htm 8-K 18440
2 BASE SALARIES FOR FISCAL YEAR 2012 d297413dex1019.htm EX-10.19 24440
  Complete submission text file 0001193125-12-046870.txt   44106
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28298 | Film No.: 12582754
SIC: 2836 Biological Products, (No Diagnostic Substances)